Indeed, the aPL and especially the anti-β2GPI could target neurons of the human brain, and patients with these autoantibodies were found to be more prone to exhibit seizures, cognitive impairment, psychosis, and depression compared to seronegative ones (15, 29, 30). Here, APOH is linked to depressive symptom measurement.